0 CHECKOUT

Type 1 Diabetes (Juvenile Diabetes) - Pipeline Review, H1 2015

  • ID: 3275737
  • May 2015
  • 543 pages
  • Global Markets Direct
1 of 4

FEATURED COMPANIES

  • 4SC AG
  • Biocon Limited
  • Diabetology Limited
  • Grifols, S.A.
  • Merck & Co., Inc.
  • PharmaIN Corporation
  • MORE

Type 1 Diabetes (Juvenile Diabetes) - Pipeline Review, H1 2015

Summary

The‘Type 1 Diabetes (Juvenile Diabetes) - Pipeline Review, H1 2015’, provides an overview of the Type 1 Diabetes (Juvenile Diabetes)’s therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Type 1 Diabetes (Juvenile Diabetes), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Type 1 Diabetes (Juvenile Diabetes) and special features on late-stage and discontinued projects.

This report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from This proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by This team. READ MORE >

Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • 4SC AG
  • Biocon Limited
  • Diabetology Limited
  • Grifols, S.A.
  • Merck & Co., Inc.
  • PharmaIN Corporation
  • MORE

Introduction

Type 1 Diabetes (Juvenile Diabetes) Overview

Therapeutics Development

Type 1 Diabetes (Juvenile Diabetes) - Therapeutics under Development by Companies

Type 1 Diabetes (Juvenile Diabetes) - Therapeutics under Investigation by Universities/Institutes

Type 1 Diabetes (Juvenile Diabetes) - Pipeline Products Glance

Type 1 Diabetes (Juvenile Diabetes) - Products under Development by Companies

Type 1 Diabetes (Juvenile Diabetes) - Products under Investigation by Universities/Institutes

Type 1 Diabetes (Juvenile Diabetes) - Companies Involved in Therapeutics Development

Type 1 Diabetes (Juvenile Diabetes) - Therapeutics Assessment 1

Drug Profiles 1

Type 1 Diabetes (Juvenile Diabetes) - Recent Pipeline Updates 4

Type 1 Diabetes (Juvenile Diabetes) - Dormant Projects 5

Type 1 Diabetes (Juvenile Diabetes) - Discontinued Products 5

Appendix 5

List of Tables:

Number of Products under Development for Type 1 Diabetes (Juvenile Diabetes), H1 2015

Number of Products under Development for Type 1 Diabetes (Juvenile Diabetes) - Comparative Analysis, H1 2015

Number of Products under Development by Companies, H1 2015

Number of Products under Development by Companies, H1 2015 (Contd..1)

Number of Products under Development by Companies, H1 2015 (Contd..2)

Number of Products under Development by Companies, H1 2015 (Contd..3)

Number of Products under Development by Companies, H1 2015 (Contd..4)

Number of Products under Development by Companies, H1 2015 (Contd..5)

Number of Products under Development by Companies, H1 2015 (Contd..6)

Number of Products under Development by Companies, H1 2015 (Contd..7)

Number of Products under Development by Companies, H1 2015 (Contd..8)

Number of Products under Investigation by Universities/Institutes, H1 2015

Number of Products under Investigation by Universities/Institutes, H1 2015 (Contd..1)

Comparative Analysis by Late Stage Development, H1 2015

Comparative Analysis by Clinical Stage Development, H1 2015

Comparative Analysis by Early Stage Development, H1 2015

Products under Development by Companies, H1 2015

Products under Development by Companies, H1 2015 (Contd..1)

Products under Development by Companies, H1 2015 (Contd..2)

Products under Development by Companies, H1 2015 (Contd..3)

Products under Development by Companies, H1 2015 (Contd..4)

Products under Development by Companies, H1 2015 (Contd..5)

Products under Development by Companies, H1 2015 (Contd..6)

Products under Development by Companies, H1 2015 (Contd..7)

Products under Development by Companies, H1 2015 (Contd..8)

Products under Development by Companies, H1 2015 (Contd..9)

Products under Development by Companies, H1 2015 (Contd..10)

Products under Development by Companies, H1 2015 (Contd..11)

Products under Investigation by Universities/Institutes, H1 2015

Products under Investigation by Universities/Institutes, H1 2015 (Contd..1)

Type 1 Diabetes (Juvenile Diabetes) - Pipeline by 4SC AG, H1 2015

Type 1 Diabetes (Juvenile Diabetes) - Pipeline by ActogeniX NV, H1 2015

Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Adocia, H1 2015

Type 1 Diabetes (Juvenile Diabetes) - Pipeline by AiCuris GmbH & Co. KG, H1 2015

Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Amarantus Bioscience Holdings, Inc., H1 2015

Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Ambrx, Inc., H1 2015

Type 1 Diabetes (Juvenile Diabetes) - Pipeline by American Gene Technologies International Inc., H1 2015

Type 1 Diabetes (Juvenile Diabetes) - Pipeline by AntriaBio, Inc., H1 2015

Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Argos Therapeutics, Inc., H1 2015

Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Artery Therapeutics, Inc., H1 2015

Type 1 Diabetes (Juvenile Diabetes) - Pipeline by AstraZeneca PLC, H1 2015

Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Axxam SpA, H1 2015

Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Bayhill Therapeutics, Inc., H1 2015

Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Beta-Cell NV, H1 2015

Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Biocon Limited, H1 2015

Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Biodel Inc., H1 2015

Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Biogenomics Limited, H1 2015

Type 1 Diabetes (Juvenile Diabetes) - Pipeline by BioLineRx, Ltd., H1 2015

Type 1 Diabetes (Juvenile Diabetes) - Pipeline by BioTherapeutics Inc., H1 2015

Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Boehringer Ingelheim GmbH, H1 2015

Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Carlina Technologies SAS, H1 2015

Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Cellectis S.A., H1 2015

Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Compugen Ltd., H1 2015

Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Cortendo AB, H1 2015

Type 1 Diabetes (Juvenile Diabetes) - Pipeline by CTI BioPharma Corp., H1 2015

Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Daewoong Pharmaceutical Co., Ltd., H1 2015

Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Diabetology Limited, H1 2015

Type 1 Diabetes (Juvenile Diabetes) - Pipeline by DiaMedica Inc., H1 2015

Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Diasome Pharmaceuticals, Inc., H1 2015

Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Dompe Farmaceutici S.p.A., H1 2015

Type 1 Diabetes (Juvenile Diabetes) - Pipeline by DoNatur GmbH, H1 2015

Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Effimune SAS, H1 2015

Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Eli Lilly and Company, H1 2015

Type 1 Diabetes (Juvenile Diabetes) - Pipeline by EpiVax, Inc., H1 2015

Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Evotec AG, H1 2015

Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Extrawell Pharmaceutical Holdings Limited, H1 2015

Type 1 Diabetes (Juvenile Diabetes) - Pipeline by GeNeuro SA, H1 2015

Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Gilead Sciences, Inc., H1 2015

Type 1 Diabetes (Juvenile Diabetes) - Pipeline by GlaxoSmithKline plc, H1 2015 1

Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Grifols, S.A., H1 2015 1

Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Halozyme Therapeutics, Inc., H1 2015 1

Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Hanmi Pharmaceuticals, Co. Ltd., H1 2015 1

Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Hyperion Therapeutics, Inc., H1 2015 1

Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Iltoo Pharma, H1 2015 1

Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Immunocore Limited, H1 2015 1

Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Intrexon Corporation, H1 2015 1

Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Islet Sciences, Inc., H1 2015 1

Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Johnson & Johnson, H1 2015 1

Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Kamada Ltd., H1 2015 1

Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Kasiak Research Pvt. Ltd., H1 2015 1

Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Kineta, Inc., H1 2015 1

Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Kissei Pharmaceutical Co., Ltd., H1 2015 1

Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Lexicon Pharmaceuticals, Inc., H1 2015 1

Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Ligand Pharmaceuticals, Inc., H1 2015 1

Type 1 Diabetes (Juvenile Diabetes) - Pipeline by MacroGenics, Inc., H1 2015 1

Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Medestea Research & Production S.p.A., H1 2015 1

Type 1 Diabetes (Juvenile Diabetes) - Pipeline by MedImmune, LLC, H1 2015 1

Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Merck & Co., Inc., H1 2015 1

Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Merck KGaA, H1 2015 1

Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Meridigen Biotech Co., Ltd., H1 2015 1

Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Mertiva AB, H1 2015 1

Type 1 Diabetes (Juvenile Diabetes) - Pipeline by MidaSol Therapeutics LP, H1 2015 1

Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Mitsubishi Tanabe Pharma Corporation, H1 2015 1

Type 1 Diabetes (Juvenile Diabetes) - Pipeline by NeoStem, Inc., H1 2015 1

Type 1 Diabetes (Juvenile Diabetes) - Pipeline by NGM Biopharmaceuticals, Inc., H1 2015 1

Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Novo Nordisk A/S, H1 2015 1

Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Noxxon Pharma AG, H1 2015 1

Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Omni Bio Pharmaceutical Inc., H1 2015 1

Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Opexa Therapeutics, Inc., H1 2015 1

Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Oramed Pharmaceuticals, Inc., H1 2015 1

Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Orgenesis, Inc., H1 2015 1

Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Paras Biopharmaceuticals Finland Oy, H1 2015 1

Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Pfizer Inc., H1 2015 1

Type 1 Diabetes (Juvenile Diabetes) - Pipeline by PharmaCyte Biotech, Inc., H1 2015 1

Type 1 Diabetes (Juvenile Diabetes) - Pipeline by PharmaIN Corporation, H1 2015 1

Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Progen Pharmaceuticals Limited, H1 2015 1

Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Prometheon Pharma, LLC, H1 2015 1

Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Provid Pharmaceuticals, Inc., H1 2015 1

Type 1 Diabetes (Juvenile Diabetes) - Pipeline by RedHill Biopharma Ltd., H1 2015 1

Type 1 Diabetes (Juvenile Diabetes) - Pipeline by REGiMMUNE Corporation, H1 2015 1

Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Sanofi, H1 2015 1

Type 1 Diabetes (Juvenile Diabetes) - Pipeline by SEKRIS Biomedical, Inc., H1 2015 1

Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Selecta Biosciences, Inc., H1 2015 1

Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Shreya Life Sciences Pvt. Ltd., H1 2015 1

Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Therapix Biosciences Ltd, H1 2015 1

Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Thermalin Diabetes, LLC, H1 2015 1

Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Toleranzia AB, H1 2015 1

Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Transgene Biotek Limited, H1 2015 1

Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Uni-Bio Science Group Ltd., H1 2015 1

Type 1 Diabetes (Juvenile Diabetes) - Pipeline by ViaCyte, Inc., H1 2015 1

Type 1 Diabetes (Juvenile Diabetes) - Pipeline by Visionary Pharmaceuticals, Inc., H1 2015 1

Type 1 Diabetes (Juvenile Diabetes) - Pipeline by X-BODY BioSciences, Inc., H1 2015 1

Type 1 Diabetes (Juvenile Diabetes) - Pipeline by XOMA Corporation, H1 2015 1

Assessment by Monotherapy Products, H1 2015 1

Assessment by Combination Products, H1 2015 1

Number of Products by Stage and Target, H1 2015 1

Number of Products by Stage and Mechanism of Action, H1 2015 1

Number of Products by Stage and Route of Administration, H1 2015 1

Number of Products by Stage and Molecule Type, H1 2015 1

Type 1 Diabetes (Juvenile Diabetes) Therapeutics - Recent Pipeline Updates, H1 2015 4

Type 1 Diabetes (Juvenile Diabetes) - Dormant Projects, H1 2015 5

Type 1 Diabetes (Juvenile Diabetes) - Dormant Projects (Contd..1), H1 2015 5

Type 1 Diabetes (Juvenile Diabetes) - Dormant Projects (Contd..2), H1 2015 5

Type 1 Diabetes (Juvenile Diabetes) - Dormant Projects (Contd..3), H1 2015 5

Type 1 Diabetes (Juvenile Diabetes) - Dormant Projects (Contd..4), H1 2015 5

Type 1 Diabetes (Juvenile Diabetes) - Dormant Projects (Contd..5), H1 2015 5

Type 1 Diabetes (Juvenile Diabetes) - Dormant Projects (Contd..6), H1 2015 5

Type 1 Diabetes (Juvenile Diabetes) - Dormant Projects (Contd..7), H1 2015 5

Type 1 Diabetes (Juvenile Diabetes) - Discontinued Products, H1 2015 5

Type 1 Diabetes (Juvenile Diabetes) - Discontinued Products (Contd..1), H1 2015 5

List of Figures:

Number of Products under Development for Type 1 Diabetes (Juvenile Diabetes), H1 2015

Number of Products under Development for Type 1 Diabetes (Juvenile Diabetes) - Comparative Analysis, H1 2015

Number of Products under Development by Companies, H1 2015

Number of Products under Investigation by Universities/Institutes, H1 2015

Comparative Analysis by Late Stage Development, H1 2015

Comparative Analysis by Clinical Stage Development, H1 2015

Comparative Analysis by Early Stage Products, H1 2015

Assessment by Monotherapy Products, H1 2015 1

Assessment by Combination Products, H1 2015 1

Number of Products by Top 10 Targets, H1 2015 1

Number of Products by Stage and Top 10 Targets, H1 2015 1

Number of Products by Top 10 Mechanism of Actions, H1 2015 1

Number of Products by Stage and Top 10 Mechanism of Actions, H1 2015 1

Number of Products by Top 10 Routes of Administration, H1 2015 1

Number of Products by Stage and Top 10 Routes of Administration, H1 2015 1

Number of Products by Top 10 Molecule Types, H1 2015 1

Number of Products by Stage and Top 10 Molecule Types, H1 2015

Note: Product cover images may vary from those shown
3 of 4

- 4SC AG
- ActogeniX NV
- Adocia
- AiCuris GmbH & Co. KG
- Amarantus Bioscience Holdings, Inc.
- Ambrx, Inc.
- American Gene Technologies International Inc.
- AntriaBio, Inc.
- Argos Therapeutics, Inc.
- Artery Therapeutics, Inc.
- AstraZeneca PLC
- Axxam SpA
- Bayhill Therapeutics, Inc.
- Beta-Cell NV
- Biocon Limited
- Biodel Inc.
- Biogenomics Limited
- BioLineRx, Ltd.
- BioTherapeutics Inc.
- Boehringer Ingelheim GmbH
- Carlina Technologies SAS
- Cellectis S.A.
- Compugen Ltd.
- Cortendo AB
- CTI BioPharma Corp.
- Daewoong Pharmaceutical Co., Ltd.
- Diabetology Limited
- DiaMedica Inc.
- Diasome Pharmaceuticals, Inc.
- Dompe Farmaceutici S.p.A.
- DoNatur GmbH
- Effimune SAS
- Eli Lilly and Company
- EpiVax, Inc.
- Evotec AG
- Extrawell Pharmaceutical Holdings Limited
- GeNeuro SA
- Gilead Sciences, Inc.
- GlaxoSmithKline plc
- Grifols, S.A.
- Halozyme Therapeutics, Inc.
- Hanmi Pharmaceuticals, Co. Ltd.
- Hyperion Therapeutics, Inc.
- Iltoo Pharma
- Immunocore Limited
- Intrexon Corporation
- Islet Sciences, Inc.
- Johnson & Johnson
- Kamada Ltd.
- Kasiak Research Pvt. Ltd.
- Kineta, Inc.
- Kissei Pharmaceutical Co., Ltd.
- Lexicon Pharmaceuticals, Inc.
- Ligand Pharmaceuticals, Inc.
- MacroGenics, Inc.
- Medestea Research & Production S.p.A.
- MedImmune, LLC
- Merck & Co., Inc.
- Merck KGaA
- Meridigen Biotech Co., Ltd.
- Mertiva AB
- MidaSol Therapeutics LP
- Mitsubishi Tanabe Pharma Corporation
- NeoStem, Inc.
- NGM Biopharmaceuticals, Inc.
- Novo Nordisk A/S
- Noxxon Pharma AG
- Omni Bio Pharmaceutical Inc.
- Opexa Therapeutics, Inc.
- Oramed Pharmaceuticals, Inc.
- Orgenesis, Inc.
- Paras Biopharmaceuticals Finland Oy
- Pfizer Inc.
- PharmaCyte Biotech, Inc.
- PharmaIN Corporation
- Progen Pharmaceuticals Limited
- Prometheon Pharma, LLC
- Provid Pharmaceuticals, Inc.
- RedHill Biopharma Ltd.
- REGiMMUNE Corporation
- Sanofi
- SEKRIS Biomedical, Inc.
- Selecta Biosciences, Inc.
- Shreya Life Sciences Pvt. Ltd.
- Therapix Biosciences Ltd
- Thermalin Diabetes, LLC
- Toleranzia AB
- Transgene Biotek Limited
- Uni-Bio Science Group Ltd.
- ViaCyte, Inc.
- Visionary Pharmaceuticals, Inc.
- X-BODY BioSciences, Inc.
- XOMA Corporation

Note: Product cover images may vary from those shown
4 of 4
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a site license, allowing all users within a given geographical location of your organisation access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is an enterprise license, allowing all employees within your organisation access to the product.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS from Db

Our Clients

  • Merck & Co., Inc.
  • Celgene Corporation
  • GlaxoSmithKline PLC
  • Genentech, Inc.
  • Johnson & Johnson Services, Inc.
  • ViiV Healthcare